Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct;74(10):e13577.
doi: 10.1111/ijcp.13577. Epub 2020 Aug 27.

AA amyloidosis associated with Fabry disease

Alexandre Terré  1 , Bertrand Knebelmann  2 , David Buob  3 , Marion Rabant  4 , Olivier Lidove  5   6 , Samuel Deshayes  7 , Nacera Ouali  8 , Gilles Grateau  1   8 , Sophie Georgin-Lavialle  1   8
Affiliations
Case Reports

AA amyloidosis associated with Fabry disease

Alexandre Terré et al. Int J Clin Pract. 2020 Oct.

Abstract

Background: Fabry disease (FD) is the second most common lysosomal storage disorder, carrying a large morbidity and mortality. It has been recently reported that lysosomal storage disorders could cause inflammation and, subsequently, AA amyloidosis (AAA). Our aim was to describe AAA cases occurring in the course of FD.

Patients and methods: We described two patients displaying both AAA and FD and an additional case from the literature.

Results: Three female patients originating from Europe (n = 2) and Algeria (n = 1) harboured heterozygous GLA mutations. The median age at AAA diagnosis was 61 years old. The diagnosis of Fabry was made before the diagnosis of AAA (n = 1) or concomitantly (n = 2). At AAA diagnosis, two patients displayed a nephrotic syndrome; all had inflammation.

Conclusion: Fabry disease can be associated with AAA, suggesting that an inflammatory component could exist in this genetic disease.

PubMed Disclaimer

References

REFERENCES

    1. Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3’ untranslated region. Proc Natl Acad Sci USA. 1988;85:3903-3907.
    1. Zarate YA, Hopkin RJ. Fabry’s disease. Lancet. 2008;372:1427-1435.
    1. Mauhin W, Lidove O, Masat E, et al. Innate and adaptive immune response in Fabry disease. JIMD Rep. 2015;22:1-10.
    1. Pereira CS, Azevedo O, Maia ML, Dias AF, Sa-Miranda C, Macedo MF. Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease. Mol Genet Metab. 2013;108:241-248.
    1. Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015;10:321-344.

Publication types

Substances